Regencell Bioscience Holdings Stock Price on December 11, 2024
| RGC Stock | USD 5.17 0.35 7.26% |
If you're considering investing in Regencell Stock, it is important to understand the factors that can impact its price. As of today, the current price of Regencell Bioscience stands at 5.17, as last reported on the 5th of January, with the highest price reaching 5.17 and the lowest price hitting 4.80 during the day. Regencell Bioscience appears to be very risky, given 3 months investment horizon. Regencell Bioscience maintains Sharpe Ratio (i.e., Efficiency) of 0.0685, which implies the firm had a 0.0685% return per unit of risk over the last 3 months. By analyzing Regencell Bioscience's technical indicators, you can evaluate if the expected return of 0.58% is justified by implied risk. Please evaluate Regencell Bioscience's Coefficient Of Variation of 3201.54, semi deviation of 5.87, and Risk Adjusted Performance of 0.0344 to confirm if our risk estimates are consistent with your expectations.
The current year's Total Stockholder Equity is expected to grow to about 7.8 M, whereas Common Stock Shares Outstanding is forecasted to decline to about 11.1 M. . At present, Regencell Bioscience's Price To Operating Cash Flows Ratio is projected to decrease significantly based on the last few years of reporting. The current year's Price To Free Cash Flows Ratio is expected to grow to 10.81, whereas Price To Sales Ratio is forecasted to decline to 0.36. Regencell Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Regencell |
Sharpe Ratio = 0.0685
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | RGC | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 8.5 actual daily | 75 75% of assets are less volatile |
Expected Return
| 0.58 actual daily | 11 89% of assets have higher returns |
Risk-Adjusted Return
| 0.07 actual daily | 5 95% of assets perform better |
Based on monthly moving average Regencell Bioscience is performing at about 5% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Regencell Bioscience by adding it to a well-diversified portfolio.
Regencell Bioscience Main Headline on 11th of December 2024
Regal Owner Cineworld to Shut Six More U.K. Locations Amid R... by finance.yahoo.com
British exhibition giant Cineworld is closing a total of 11 theaters across the U.K. as part of a completed restructuring plan aimed at stabilizing the chains operations heading into 2025. Five locations Glasgow Parkhead, Bedford, Loughborough, Yate and Swindon Regent Circus were shuttered following the plans July announcement. Six additional sites in Castleford,
Regencell Bioscience Valuation on December 11, 2024
It is possible to determine the worth of Regencell Bioscience on a given historical date. On December 11, 2024 Regencell was worth 5.68 at the beginning of the trading date compared to the closed value of 5.45. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Regencell Bioscience stock. Still, in general, we apply an absolute valuation method to find Regencell Bioscience's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Regencell Bioscience where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Regencell Bioscience's related companies.
| Open | High | Low | Close | Volume | |
| 5.68 | 5.84 | 5.41 | 5.52 | 31,417 | |
12/11/2024 | 5.68 | 5.78 | 5.45 | 5.45 | 15,215 |
| 5.45 | 5.65 | 5.45 | 5.49 | 31,863 |
| Backtest Regencell Bioscience | | | Regencell Bioscience History | | | Regencell Bioscience Valuation | Previous | Next |
Regencell Bioscience Trading Date Momentum on December 11, 2024
| On December 12 2024 Regencell Bioscience Holdings was traded for 5.49 at the closing time. Highest Regencell Bioscience's price during the trading hours was 5.65 and the lowest price during the day was 5.45 . The net volume was 31.9 K. The overall trading history on the 12th of December 2024 contributed to the next trading period price growth. The trading delta at closing time to the next next day price was 0.73% . The trading delta at closing time to current price is 11.93% . |
Regencell Bioscience Fundamentals Correlations and Trends
By evaluating Regencell Bioscience's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Regencell Bioscience's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Regencell financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Regencell Bioscience Stock history
Regencell Bioscience investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Regencell is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Regencell Bioscience will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Regencell Bioscience stock prices may prove useful in developing a viable investing in Regencell Bioscience
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 11.7 M | 11.1 M | |
| Net Loss | -6.7 M | -6.4 M |
Regencell Bioscience Stock Technical Analysis
Regencell Bioscience technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Regencell Bioscience Period Price Range
Low | January 5, 2025
| High |
0.00 | 0.00 |
Regencell Bioscience Holdings cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Regencell Bioscience January 5, 2025 Market Strength
Market strength indicators help investors to evaluate how Regencell Bioscience stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Regencell Bioscience shares will generate the highest return on investment. By undertsting and applying Regencell Bioscience stock market strength indicators, traders can identify Regencell Bioscience Holdings entry and exit signals to maximize returns
Regencell Bioscience Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Regencell Bioscience's price direction in advance. Along with the technical and fundamental analysis of Regencell Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Regencell to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0344 | |||
| Jensen Alpha | 0.248 | |||
| Total Risk Alpha | 0.1265 | |||
| Sortino Ratio | 0.0408 | |||
| Treynor Ratio | 0.3903 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Regencell Stock analysis
When running Regencell Bioscience's price analysis, check to measure Regencell Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Regencell Bioscience is operating at the current time. Most of Regencell Bioscience's value examination focuses on studying past and present price action to predict the probability of Regencell Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Regencell Bioscience's price. Additionally, you may evaluate how the addition of Regencell Bioscience to your portfolios can decrease your overall portfolio volatility.
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Fundamental Analysis View fundamental data based on most recent published financial statements |